Track the NextCell Pharma AB share price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are quoted on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, NextCell Pharma AB has published 10 public disclosures. Market capitalisation: €109.7m. The latest transaction was disclosed on 3 June 2025 (Other). Among the most active insiders: Patrik Fagerholm. All data is free.
10
Insider Decl.
n/a
Thresholds
€1,196
3 ops.
Buy Volume
€93,715
1 ops.
Sell Volume
42Σ signal
Buys €1,196€93,715 Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
60,000 shares@ SEK 15.80100.0% of flowAktieISINISIN SE0009723125FI:A001P854-1
10 of 10 declarations
Acerca de NextCell Pharma AB
NextCell Pharma AB es una empresa de biotecnología enfocada en el desarrollo de terapias celulares para el tratamiento de la diabetes tipo 1. Cotiza en la Bolsa de Estocolmo (XSTO).